Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25153677 | 0.90 | RAB9A (0.57) | RAB9ALMNAPKMHSD17B10MEN1 | |
| SCHEMBL3725801 | 0.78 | LMNA (0.69) | RAB9ALMNAPKMHSD17B10ALDH1A1 | |
| SCHEMBL3727761 | 0.78 | LMNA (0.65) | RAB9ALMNAPKMHSD17B10MEN1 | |
| SCHEMBL3733443 | 0.77 | RAB9A (0.61) | RAB9ALMNAPKMHSD17B10MEN1 | |
| SCHEMBL3727157 | 0.77 | MEN1 (0.72) | RAB9ALMNAPKMHSD17B10MEN1 | |
| SCHEMBL3729145 | 0.76 | ALDH1A1 (0.52) | RAB9ALMNAPKMHSD17B10MEN1 | |
| SCHEMBL3734173 | 0.74 | RAB9A (0.65) | RAB9ALMNAPKMHSD17B10MEN1 | |
| SCHEMBL3728504 | 0.73 | ALDH1A1 (0.56) | RAB9ALMNAPKMHSD17B10MEN1 | |
| SCHEMBL3728220 | 0.73 | ALDH1A1 (0.52) | RAB9ALMNAPKMHSD17B10MEN1 | |
| SCHEMBL10755428 | 0.70 | LMNA (0.62) | RAB9ALMNAPKMHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | BOUILLOT ANNE MARIE JEANNE | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100120669-A1 | THIADIAZOLE DERIVATIVES, INHIBITORS OF STEAROYL-COA DESATURASE | SCD, SCD5, FADS2 | RAB9A 3330/4885LMNA 2761/4885PKM 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.